Literature DB >> 10770344

Adherence to colposcopy among women with HIV infection.

H E Cejtin1, E Komaroff, L S Massad, A Korn, J B Schmidt, D Eisenberger-Matiyahu, E Stier.   

Abstract

UNLABELLED: In the general population, nonadherence to the recommendation to have colposcopy in women with abnormal cytologic smears is estimated at 30% to 80%, but studies have failed to identify consistent risk factors for nonadherence. The purpose of this analysis is to assess adherence to colposcopy in a subset of participants in the Women's Interagency HIV Study (WIHS), an ongoing multisite longitudinal study of HIV infection in women in the United States and determine factors associated with nonadherence. Identification of such predictors would be useful in designing strategies to improve adherence in this group.
METHODS: Adherence to colposcopy was examined in a cohort of 462 women with, or at risk for, HIV infection with abnormal cervical cytology on entry into WIHS. Adherence was defined as having colposcopy done within 6 months of an abnormal cytology result.
RESULTS: Overall adherence to colposcopy was 65% (302 of 462). A multivariate logistic regression model revealed that the odds of adherence were significantly lower for the women who were HIV-infected (p = .011), current crack/cocaine users (p = .040), ever too ill to get medical care (p = .033), not recruited by WIHS study staff (p = .004), and less concerned about the care of their children (p = .037). Among HIV-seropositive women, low CD4 counts, high viral loads, and presence of AIDS-defining illness were not predictive of nonadherence. DISCUSSION: Adherence to colposcopy among WIHS participants was at the upper limit of the reported range in the United States. Chemical dependency and domestic violence may negatively impact on colposcopy adherence whereas supportive study personnel, having health insurance, and concerns about raising one's children appear to be motivators for adherence to colposcopy in this study. HIV infection was a risk factor for nonadherence, but markers of advanced disease were not predictive of nonadherence.

Entities:  

Mesh:

Year:  1999        PMID: 10770344     DOI: 10.1097/00126334-199911010-00005

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  20 in total

1.  Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-12-05       Impact factor: 2.681

Review 2.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

3.  Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: impact of HIV infection.

Authors:  L Stewart Massad; Christopher B Pierce; Howard Minkoff; D Heather Watts; Teresa M Darragh; Lorraine Sanchez-Keeland; Rodney L Wright; Christine Colie; Gypsyamber D'Souza
Journal:  Int J Cancer       Date:  2013-10-29       Impact factor: 7.396

4.  The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.

Authors:  Lynn E Sullivan; Michael Botsko; Chinazo O Cunningham; Patrick G O'Connor; David Hersh; Jennifer Mitty; Paula J Lum; Richard S Schottenfeld; David A Fiellin
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

5.  Risk factors for nonadherence with Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; C Robert Horsburgh; L Adrienne Cupples; Ann Aschengrau; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-08-31       Impact factor: 2.681

6.  Incidence of cervical precancers among HIV-seropositive women.

Authors:  L Stewart Massad; Xianhong Xie; Gypsyamber D'Souza; Teresa M Darragh; Howard Minkoff; Rodney Wright; Christine Colie; Lorraine Sanchez-Keeland; Howard D Strickler
Journal:  Am J Obstet Gynecol       Date:  2014-12-10       Impact factor: 8.661

Review 7.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

8.  Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.

Authors:  Alison G Abraham; Gypsyamber D'Souza; Yuezhou Jing; Stephen J Gange; Timothy R Sterling; Michael J Silverberg; Michael S Saag; Sean B Rourke; Anita Rachlis; Sonia Napravnik; Richard D Moore; Marina B Klein; Mari M Kitahata; Gregory D Kirk; Robert S Hogg; Nancy A Hessol; James J Goedert; M John Gill; Kelly A Gebo; Joseph J Eron; Eric A Engels; Robert Dubrow; Heidi M Crane; John T Brooks; Ronald J Bosch; Howard D Strickler
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

9.  HIV women's health: a study of gynecological healthcare service utilization in a U.S. urban clinic population.

Authors:  Monique A Tello; Hsin-Chieh Yeh; Jean M Keller; Mary C Beach; Jean R Anderson; Richard D Moore
Journal:  J Womens Health (Larchmt)       Date:  2008-12       Impact factor: 2.681

10.  Long-term incidence of cervical cancer in women with human immunodeficiency virus.

Authors:  L Stewart Massad; Eric C Seaberg; D Heather Watts; Howard Minkoff; Alexandra M Levine; Donna Henry; Christine Colie; Teresa M Darragh; Nancy A Hessol
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.